EGFR and non-small cell lung carcinoma: <h4>Background</h4>There are about 10-15% of uncommon EGFR mutations found in NSCLC patients, and their sensitivity to EGFR TKIs still lack sufficient clinical evidence, especially for rare compound mutations.